1.0Pharmacology/pharmBetsy Clarke/pharm/author/bclarke/rich600338<blockquote class="wp-embedded-content" data-secret="6q9Cfefdez"><a href="/pharm/directory/john-p-morris-iv-phd/">John P. Morris IV, PhD</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="/pharm/directory/john-p-morris-iv-phd/embed/#?secret=6q9Cfefdez" width="600" height="338" title="“John P. Morris IV, PhD” — Pharmacology" data-secret="6q9Cfefdez" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript"> /* <![CDATA[ */ /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); /* ]]> */ </script> /pharm/wp-content/uploads/sites/930/2020/05/John-Morris-2023-400-3.jpg400400Research Interests Oncogene and tumor suppressor networks Malignant specification and lineage plasticity Evolution of cancer epigenetic and genomic heterogeneity Research Synopsis Tumorigenesis reflects the emergence of lineages that no longer conform to the differentiation programs essential for organ development, maintenance, and regeneration.  The Morris Lab strives to understand how cancer drivers initiate and maintain lineages that no … Read more